Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -9.2% | -38.4% | 0 / 3 | -9.2% | +1.46 pp | +0.00 pp | +12.1% | 0.08 | 14.50 | 23,7 | −9,2% | 1,2 | −9,2% | 14.50 | 13.60 | +6,6% |
| Pts | 0 | 0 | 0 | 0 | 8 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 23.600 (close price on 2026-05-26)EPS (TTM): 1.627
Financial charts
1.Revenue & growth
VND bn23,7Q2/26
1.Revenue & growth
VND bn23,7Q2/26
2.Profit & growth
VND bn0,70Q2/26
3.Profit mix (Penman)
VND bn5,55Q2/26
4.Margins & cost structure
%26.6%Q2/26
5.Returns & cash cycle
% · days15.0%Q2/26
6.Earnings quality & cash
VND bn5,64Q2/26
7.Asset structure
VND bn53,1Q2/26
8.Funding & debt health
VND bn · times53,1Q2/26
9.Revenue backlog
VND bn0,62Q2/26
10.Valuation
times · %16,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %233Q2/26
Adjusted EPS growth, latest quarter
-47.4%
Average adjusted EPS growth, 3 quarters
-51.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26